INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY SDZ-NIM-811, A NONIMMUNOSUPPRESSIVE CYCLOSPORINE ANALOG

被引:158
作者
ROSENWIRTH, B [1 ]
BILLICH, A [1 ]
DATEMA, R [1 ]
DONATSCH, P [1 ]
HAMMERSCHMID, F [1 ]
HARRISON, R [1 ]
HIESTAND, P [1 ]
JAKSCHE, H [1 ]
MAYER, P [1 ]
PEICHL, P [1 ]
QUESNIAUX, V [1 ]
SCHATZ, F [1 ]
SCHUURMAN, HJ [1 ]
TRABER, R [1 ]
WENGER, R [1 ]
WOLFF, B [1 ]
ZENKE, G [1 ]
ZURINI, M [1 ]
机构
[1] SANDOZ PHARMA AG,CH-4002 BASEL,SWITZERLAND
关键词
D O I
10.1128/AAC.38.8.1763
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
(Me-Ile-4)cyclosporin (SDZ NIM 811) is a 4-substituted cyclosporin which is devoid of immunosuppressive activity but retains full capacity for binding to cyclophilin and exhibits potent anti-human immunodeficiency virus type 1 (HIV-1) activity. SDZ NIM 811 selectively inhibits HIV-1 replication in T4 lymphocyte cell lines, in a monocytic cell line, and in HeLa T4 cells. Furthermore, its antiviral activity against laboratory strains and against clinical isolates from geographically distinct regions in primary T4 lymphocytes and in primary monocytes (50% inhibitory concentration = 0.011 to 0.057 mu g/ml) was demonstrated. SDZ NIM 811 does not inhibit proviral gene expression or virus-specific enzyme functions, either free or bound to cyclophilin. The compound does not influence CD4 expression or inhibit fusion between virus-infected and uninfected cells. SDZ NIM 811 was, however, found to block formation of infectious particles from chronically infected cells. Oral administration to mice, rats, dogs, and monkeys resulted in levels in blood considerably exceeding the drug concentration, which completely blocked virus replication in primary cells. SDZ NIM 811 caused changes of toxicity parameters in rats to a smaller degree than cyclosporine (formerly cyclosporin A). Thus, the potent and selective anti-HIV-l activity of SDZ NIM 811 and its favorable pharmacokinetic behavior together with its lower nephrotoxicity than that of cyclosporine make this compound a promising candidate for development as an anti-HIV drug.
引用
收藏
页码:1763 / 1772
页数:10
相关论文
共 55 条
[1]   AIDS AND RELATED SYNDROMES AS A VIRAL-INDUCED AUTOIMMUNE-DISEASE OF THE IMMUNE-SYSTEM - AN ANTI-MHC-II DISORDER - THERAPEUTIC IMPLICATIONS [J].
ANDRIEU, JM ;
EVEN, P ;
VENET, A .
AIDS RESEARCH, 1986, 2 (03) :163-174
[2]  
ANDRIEU JM, 1988, CLIN IMMUNOL IMMUNOP, V46, P181
[3]  
BAUMANN G, 1992, TRANSPLANT P, V24, P43
[4]   MOLECULAR MECHANISMS OF IMMUNOSUPPRESSION [J].
BAUMANN, G ;
ZENKE, G ;
WENGER, R ;
HIESTAND, P ;
QUESNIAUX, V ;
ANDERSEN, E ;
SCHREIER, MH .
JOURNAL OF AUTOIMMUNITY, 1992, 5 :67-72
[5]   HIV-1 INTEGRASE - HIGH-LEVEL PRODUCTION AND SCREENING ASSAY FOR THE ENDONUCLEOLYTIC ACTIVITY [J].
BILLICH, A ;
SCHAUER, M ;
FRANK, S ;
ROSENWIRTH, B ;
BILLICH, S .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (02) :113-119
[6]   PURIFICATION, ASSAY AND KINETIC FEATURES OF HIV-1 PROTEINASE [J].
BILLICH, A ;
HAMMERSCHMID, F ;
WINKLER, G .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03) :265-272
[7]  
BOREL JF, 1989, PHARMACOL REV, V41, P239
[8]  
BURKINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125
[9]   DISTINCT BIOLOGICAL AND SEROLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUSES FROM THE BRAIN [J].
CHENGMAYER, C ;
LEVY, JA .
ANNALS OF NEUROLOGY, 1988, 23 :S58-S61
[10]   SPECIFIC BINDING OF HIV-1 RECOMBINANT REV PROTEIN TO THE REV-RESPONSIVE ELEMENT INVITRO [J].
DALY, TJ ;
COOK, KS ;
GRAY, GS ;
MAIONE, TE ;
RUSCHE, JR .
NATURE, 1989, 342 (6251) :816-819